chr9-14722499-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_005454.3(CER1):c.174C>T(p.Val58Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00184 in 1,614,170 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00091 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 9 hom. )
Consequence
CER1
NM_005454.3 synonymous
NM_005454.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.18
Genes affected
CER1 (HGNC:1862): (cerberus 1, DAN family BMP antagonist) This gene encodes a cytokine member of the cysteine knot superfamily, characterized by nine conserved cysteines and a cysteine knot region. The cerberus-related cytokines, together with Dan and DRM/Gremlin, represent a group of bone morphogenetic protein (BMP) antagonists that can bind directly to BMPs and inhibit their activity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 9-14722499-G-A is Benign according to our data. Variant chr9-14722499-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2659080.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-2.18 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 9 gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000913 AC: 139AN: 152174Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
139
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000732 AC: 184AN: 251464 AF XY: 0.000751 show subpopulations
GnomAD2 exomes
AF:
AC:
184
AN:
251464
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00193 AC: 2824AN: 1461878Hom.: 9 Cov.: 33 AF XY: 0.00185 AC XY: 1349AN XY: 727240 show subpopulations
GnomAD4 exome
AF:
AC:
2824
AN:
1461878
Hom.:
Cov.:
33
AF XY:
AC XY:
1349
AN XY:
727240
Gnomad4 AFR exome
AF:
AC:
9
AN:
33480
Gnomad4 AMR exome
AF:
AC:
0
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
2
AN:
26136
Gnomad4 EAS exome
AF:
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
AC:
19
AN:
86256
Gnomad4 FIN exome
AF:
AC:
0
AN:
53418
Gnomad4 NFE exome
AF:
AC:
2550
AN:
1112000
Gnomad4 Remaining exome
AF:
AC:
244
AN:
60396
Heterozygous variant carriers
0
167
334
501
668
835
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000913 AC: 139AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.000792 AC XY: 59AN XY: 74488 show subpopulations
GnomAD4 genome
AF:
AC:
139
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
59
AN XY:
74488
Gnomad4 AFR
AF:
AC:
0.00026469
AN:
0.00026469
Gnomad4 AMR
AF:
AC:
0.0000654022
AN:
0.0000654022
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000207383
AN:
0.000207383
Gnomad4 FIN
AF:
AC:
0.0000941797
AN:
0.0000941797
Gnomad4 NFE
AF:
AC:
0.00182267
AN:
0.00182267
Gnomad4 OTH
AF:
AC:
0.000473037
AN:
0.000473037
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
CER1: BP4, BP7 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at